Reviewing Basel Medical Group (NASDAQ:BMGL) and Solventum (NYSE:SOLV)

Basel Medical Group (NASDAQ:BMGL) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Valuation & Earnings

This table compares Basel Medical Group and Solventum”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	1.46	-$9.50 million	N/A	N/A
Solventum	$8.32 billion	1.63	$1.56 billion	$8.16	9.59

Solventum has higher revenue and earnings than Basel Medical Group.

Profitability

This table compares Basel Medical Group and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Solventum	17.33%	23.51%	7.63%

Analyst Ratings

This is a breakdown of recent ratings and target prices for Basel Medical Group and Solventum, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
Solventum	1	5	7	0	2.46

Solventum has a consensus price target of $83.73, indicating a potential upside of 7.04%. Given Solventum’s stronger consensus rating and higher probable upside, analysts plainly believe Solventum is more favorable than Basel Medical Group.

Risk and Volatility

Basel Medical Group has a beta of 0.15, meaning that its stock price is 85% less volatile than the S&P 500. Comparatively, Solventum has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500.

Summary

Solventum beats Basel Medical Group on 10 of the 10 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.